Biblio
Export 1209 results:
Author Title Type [ Year
Filters: First Letter Of Last Name is R [Clear All Filters]
“Depression and Alzheimer's Disease Biomarkers Predict Driving Decline.”, J Alzheimers Dis, vol. 66, no. 3, pp. 1213-1221, 2018.
, “Depressive Symptoms Are Associated with Cognitive Function in the Elderly with Type 2 Diabetes.”, J Alzheimers Dis, vol. 65, no. 2, pp. 683-692, 2018.
, “Designing an Internet-Based Multidomain Intervention for the Prevention of Cardiovascular Disease and Cognitive Impairment in Older Adults: The HATICE Trial.”, J Alzheimers Dis, vol. 62, no. 2, pp. 649-663, 2018.
, “Detection of Dementia Cases in Two Swedish Health Registers: A Validation Study.”, J Alzheimers Dis, vol. 61, no. 4, pp. 1301-1310, 2018.
, “Diagnosis of Mild Cognitive Impairment Due to Alzheimer's Disease with Transcranial Magnetic Stimulation.”, J Alzheimers Dis, vol. 65, no. 1, pp. 221-230, 2018.
, “Diaphanous 1 (DIAPH1) is Highly Expressed in the Aged Human Medial Temporal Cortex and Upregulated in Myeloid Cells During Alzheimer's Disease.”, J Alzheimers Dis, vol. 64, no. 3, pp. 995-1007, 2018.
, “Diazepam Toxicity Presenting as a Dementia Disorder.”, J Alzheimers Dis, vol. 66, no. 3, pp. 935-938, 2018.
, “Differences Between Women and Men in Incidence Rates of Dementia and Alzheimer's Disease.”, J Alzheimers Dis, vol. 64, no. 4, pp. 1077-1083, 2018.
, “Differentiating between Alzheimer's Disease and Vascular Cognitive Impairment: Is the "Memory Versus Executive Function" Contrast Still Relevant?”, J Alzheimers Dis, vol. 63, no. 2, pp. 625-633, 2018.
, “Dipeptidyl-Peptidase Activity of Meprin β Links N-truncation of Aβ with Glutaminyl Cyclase-Catalyzed pGlu-Aβ Formation.”, J Alzheimers Dis, vol. 66, no. 1, pp. 359-375, 2018.
, “Dipeptidyl-Peptidase Activity of Meprin β Links N-truncation of Aβ with Glutaminyl Cyclase-Catalyzed pGlu-Aβ Formation.”, J Alzheimers Dis, vol. 66, no. 1, pp. 359-375, 2018.
, “Distinct Neuroanatomical Correlates of Neuropsychiatric Symptoms in the Three Main Forms of Genetic Frontotemporal Dementia in the GENFI Cohort.”, J Alzheimers Dis, vol. 65, no. 1, pp. 147-163, 2018.
, “Distinct Neuroanatomical Correlates of Neuropsychiatric Symptoms in the Three Main Forms of Genetic Frontotemporal Dementia in the GENFI Cohort.”, J Alzheimers Dis, vol. 65, no. 1, pp. 147-163, 2018.
, “Dual-Task Gait and Alzheimer's Disease Genetic Risk in Cognitively Normal Adults: A Pilot Study.”, J Alzheimers Dis, vol. 64, no. 4, pp. 1137-1148, 2018.
, “Early Detection of Alzheimer's Disease Based on the Patient's Creative Drawing Process: First Results with a Novel Neuropsychological Testing Method.”, J Alzheimers Dis, vol. 63, no. 2, pp. 675-687, 2018.
, “Early Intervention with a Multi-Ingredient Dietary Supplement Improves Mood and Spatial Memory in a Triple Transgenic Mouse Model of Alzheimer's Disease.”, J Alzheimers Dis, vol. 64, no. 3, pp. 835-857, 2018.
, “The Effects and Meanings of Receiving a Diagnosis of Mild Cognitive Impairment or Alzheimer's Disease When One Lives Alone.”, J Alzheimers Dis, vol. 61, no. 4, pp. 1517-1529, 2018.
, “Endocannabinoid and Muscarinic Signaling Crosstalk in the 3xTg-AD Mouse Model of Alzheimer's Disease.”, J Alzheimers Dis, vol. 64, no. 1, pp. 117-136, 2018.
, “Endogenous Murine Amyloid-β Peptide Assembles into Aggregates in the Aged C57BL/6J Mouse Suggesting These Animals as a Model to Study Pathogenesis of Amyloid-β Plaque Formation.”, J Alzheimers Dis, vol. 61, no. 4, pp. 1425-1450, 2018.
, “Epigenetic Drug Repositioning for Alzheimer's Disease Based on Epigenetic Targets in Human Interactome.”, J Alzheimers Dis, vol. 61, no. 1, pp. 53-65, 2018.
, “Epigenetic Drug Repositioning for Alzheimer's Disease Based on Epigenetic Targets in Human Interactome.”, J Alzheimers Dis, vol. 61, no. 1, pp. 53-65, 2018.
, “Episodic Memory and Learning Dysfunction Over an 18-Month Period in Preclinical and Prodromal Alzheimer's Disease.”, J Alzheimers Dis, vol. 65, no. 3, pp. 977-988, 2018.
, “Episodic Memory and Learning Dysfunction Over an 18-Month Period in Preclinical and Prodromal Alzheimer's Disease.”, J Alzheimers Dis, vol. 65, no. 3, pp. 977-988, 2018.
, “Epitomic Characterization of the Specificity of the Anti-Amyloid Aβ Monoclonal Antibodies 6E10 and 4G8.”, J Alzheimers Dis, vol. 66, no. 3, pp. 1235-1244, 2018.
, “Erythromyeloid-Derived TREM2: A Major Determinant of Alzheimer's Disease Pathology in Down Syndrome.”, J Alzheimers Dis, vol. 61, no. 3, pp. 1143-1162, 2018.
,